Exfoliation syndrome and heparin surface modified intraocular lenses
- PMID: 1557981
- DOI: 10.1111/j.1755-3768.1992.tb02097.x
Exfoliation syndrome and heparin surface modified intraocular lenses
Abstract
Either heparin surface modified (HSM) or regular polymethyl methacrylate (PMMA) intraocular lenses (IOLs) were implanted after extracapsular cataract extraction in 40 human eyes with exfoliation syndrome in a double-masked, randomized study. The patients were investigated preoperatively, and then 1 day, 1 week, 3, 6 and 12 months postoperatively. In eyes implanted with the HSM IOL, 26% had a fibrinoid reaction anterior to the IOL, while this complication was found in 50% of eyes implanted with the regular IOL. Pigment and cell deposits were more frequent on the regular IOLs than on the HSM lenses postoperatively. Posterior synechia formation between the iris and the implant or lens capsule was more common in the eyes with regular IOL compared to HSM IOL. No difference in visual acuity between the two groups was found either before or after surgery. The results suggest that in eyes with exfoliation syndrome, a heparin surface modified IOL reduces clinical complications associated with cataract surgery.
Similar articles
-
Incidence of posterior capsule opacification in eyes with exfoliation syndrome and heparin-surface-modified intraocular lenses.J Cataract Refract Surg. 1993 May;19(3):344-7. doi: 10.1016/s0886-3350(13)80303-3. J Cataract Refract Surg. 1993. PMID: 8501628 Clinical Trial.
-
[Cellular response one year after extracapsular cataract extraction--comparison of regular and heparin surface modified PMMA intraocular lenses].Klin Oczna. 2000;102(3):165-8. Klin Oczna. 2000. PMID: 11126169 Polish.
-
Heparin surface-modified intraocular lenses in patients with inactive uveitis or diabetes.Ophthalmology. 1998 May;105(5):843-5. doi: 10.1016/S0161-6420(98)95023-0. Ophthalmology. 1998. PMID: 9593384 Clinical Trial.
-
Complications of intraocular lenses. A historical and histopathological review.Surv Ophthalmol. 1984 Jul-Aug;29(1):1-54. doi: 10.1016/0039-6257(84)90113-9. Surv Ophthalmol. 1984. PMID: 6390763 Review.
-
Intraocular lenses.Curr Opin Ophthalmol. 1993 Feb;4(1):44-53. doi: 10.1097/00055735-199302000-00009. Curr Opin Ophthalmol. 1993. PMID: 10148291 Review.
Cited by
-
F-heparin modified intraocular lenses in Rhesus monkeys.Int J Ophthalmol. 2010;3(2):141-4. doi: 10.3980/j.issn.2222-3959.2010.02.11. Epub 2010 Jun 18. Int J Ophthalmol. 2010. PMID: 22553538 Free PMC article.
-
Visual outcome after phacoemulsification and IOL implantation in diabetic patients.Br J Ophthalmol. 1999 Sep;83(9):1036-41. doi: 10.1136/bjo.83.9.1036. Br J Ophthalmol. 1999. PMID: 10460771 Free PMC article.
-
Hydrophobic acrylic versus heparin surface-modified polymethylmethacrylate intraocular lens: a biocompatibility study.Graefes Arch Clin Exp Ophthalmol. 2003 Aug;241(8):625-30. doi: 10.1007/s00417-003-0711-z. Epub 2003 Jul 17. Graefes Arch Clin Exp Ophthalmol. 2003. PMID: 12883913 Clinical Trial.
-
A retrospective analysis of heparin-surface-modified intraocular lenses versus regular polymethylmethacrylate intraocular lenses in patients with uveitis.Doc Ophthalmol. 1996-1997;92(1):41-50. doi: 10.1007/BF02583275. Doc Ophthalmol. 1996. PMID: 9181331